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Background: There are only limited publications devoted to the synthesis of especially thiazolo[3,2-a]quinazoline
which involved reaction of 2-mercaptopropargyl quinazolin-4-one with various aryl iodides catalyzed by Pd-Cu or
by condensation of 2-mercapto-4-oxoquinazoline with chloroacetic acid, inspite of this procedure was also reported
in the literature to afford the thiazolo [2,3-b] quinazoline. So the multistep synthesis of the thiazolo[3,2-a]-
quinazoline suffered from some flaws and in this study we have synthesized a novel class of thiazoloquinazolines
by a simple and convenient method involving catalysis by 1,4-diazabicyclo[2.2.2]octane (DABCO).
Results: A new and convenient one-pot synthesis of a novel class of 2-arylidene-2H-thiazolo[3,2-a]quinazoline-1,
5-diones 9a-i was established through the reaction between methyl-2-(2-thio-cyanatoacetamido)benzoate (4) and a
variety of arylidene malononitriles 8a-i in the presence of DABCO as a mild and efficient catalytic system via a
Michael type addition reaction and a mechanism for formation of the products observed is proposed. Moreover 4
was converted to ethyl-2-[(4-oxo-3,4-dihydroquinazolin-2-yl)thio]acetate (10) upon reflux in ethanol containing
DABCO as catalyst. The latter was reacted with aromatic aldehydes and dimethylformamide dimethylacetal
(DMF-DMA) to afford a mixture of two regioselectively products with identical percentage yield, these two products
were identified as thiazolo[3,2-a]quinazoline 9,13 and thiazolo[2,3-b]quinazoline 11,12 derivatives respectively. The
structure of the compounds prepared in this study was elucidated by different spectroscopic tools of analyses also
the X-ray single crystal technique was employed in this study for structure elucidation, Z/E potential isomerism
configuration determination and to determine the regioselectivity of the reactions.
Conclusion: A simple and efficient one-pot synthesis of a novel class of 2-arylidene-2H-thiazolo[3,2-a]quinazoline-1,
5-diones 9a-i was established through DABCO catalyzed Michael type addition reaction. In addition many fused
quinazoline and quinazoline derivatives were synthesized which appeared as valuable precursors in synthetic and
medicinal chemistry.
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The synthesis of fused heterocycles has attracted consider-
able interest in heterocyclic chemistry as the fusion of bio-
dynamic heterosystems has proved to be a very attractive
and useful for the design of new molecular framework of
potential drugs with varying pharmacological activities. A
major challenge of the modern synthetic chemistry is to
design highly efficient chemical reaction sequences which
provide molecules containing maximum complexity and
structural diversity with interesting bioactivities in mini-
mum number of synthetic steps. Recently, organocatalysis
has increased spectacularly in the last few years as a result
of both the novelty of the concept and, more importantly,
the fact that the efficiency and the selectivity of many
organocatalytic reactions meet the standards of established
organic reactions. One of these organocatalysts is the 1,
4-diazabicyclo[2.2.2]octane (DABCO) which has received
considerable attention as an inexpensive, eco-friendly,
high reactive and non-toxic base catalyst for various or-
ganic transformations, affording the corresponding prod-
ucts in excellent yields with high selectivity [1-5]. We have
found that the quinazolines and condensed quinazolines
are versatile classes of fused heterocycles that are of con-
siderable interest because of the diverse range of their
biological properties and the potent pharmacological
activities such as anticancer [6,7], antitumor [8,9], anti-
oxidant [10], analgesic [11], anti-inflammatory [7,12], anti-
convulsant [13], anti HIV, antibacterial, antifungal [14-17],
antihypertensive [18], antileishmanial [19] and CNS de-
pressant activity [20]. On the other hand, the considerable
biological and medicinal activities of the thiazoles and
their derivatives have also attracted continuing interest
over the years because of their varied biological activities
exemplified as antibacterial, antifungal [21-24], antituber-
cular [25], anticancer [26-28], antidiabetic [29], anti HIV
[30] in addition to large applications in the drug develop-
ment for the treatment of many disease. So, on the basis
of the above findings the quinazoline and thiazole are
privileged structures, which attracted considerable atten-
tion in the designing of biologically active molecules and
combining them in one molecule exemplified by the
thiazoloquinazoline system it is expected to furnish bio-
logically active molecule with characteristic features. In
the last decade numerous methods have been developed
for the synthesis of highly substituted thiazoloqui-
nazoline system exemplified by thiazolo[2,3-b]quinazoline
[8,31-33], thiazolo[5,4-f]quinazoline [34,35], thiazolo[4,5-
h]quinazolin [36], thiazolo[5,4-c]quinoline [37], thiazolo
[4,3-b]quinazoline [38] and thiazolo[3,2-a]quinazoline
[39]. However, after detailed literature survey it was
observed that there were only limited publications devo-
ted to the synthesis of especially thiazolo[3,2-a]quina-
zoline which involved reaction of 2-mercaptopropargyl
quinazolin-4-one with various aryl iodides catalyzed byPd-Cu [39] or by condensation of 2-mercapto-4-
oxoquinazoline with chloroacetic acid [40], inspite of this
procedure was also reported in the literature to afford the
thiazolo[2,3-b]quinazoline. So the multistep synthesis of
thiazoloquinazolines especially thiazolo[3,2-a]quinazoline
suffered from some flaws and in continuation of our re-
search program on the synthesis of nitrogen and sulphur
containing novel heterocycles [41-43] of pharmaceutical
interest and in view of the operational simplicity in this
study we have synthesized a novel class of thiazoloqui-
nazolines by a simple and convenient method involving
catalysis by DABCO. The X-ray single crystal technique as
an advanced tool of analysis was employed in this study
for structure elucidation and for determination the
regioselectivety of the reactions.
Results and discussion
Synthetic chemistry
The synthetic strategy of our study to obtain the targe-
ted compounds began by preparing the starting mate-
rial methyl-2-(2-thiocyanatoacetamido)benzoate (4) which
prepared in two synthetic steps firstly by reacting the me-
thyl anthranilate (MA) (1) with chloroacetyl chloride (2)
to afford methyl-2-(2-chloroacetamido)benzoate (3) and
secondly by reacting the latter with ammonium thio-
cyanate in refluxing acetone. Moreover conducting the
reaction between the methyl-2-(2-chloroaceta-mido)
benzoate (3) and the ammonium thiocyanate in absolute
methanol afford two products depending on the refluxing
time, 4 was formed after 6h while the methyl-2-[(4-oxo-
3,4-dihydroquinazolin-2-yl)thio]acetate (5) was formed
after 12 h and not compound 6 or 7 [43,44]. Also com-
pound 5 can be obtained by refluxing the formed methyl-
2-(2-thiocyanatoacetamido)benzoate (4) in methanol [45]
(cf. Schemes 1 and 2). The structure of compounds 3, 4
and 5 was confirmed through the X-ray single crystal
structure determination (cf. Figures 1, 2, 3).
Now it was of interest to explore the scope and
limitations and generality of the methyl-2-(2-thiocyana-
toacetamido)benzoate (4) as a precursor for the synthesis
of some polyfunctionally substituted fused thiazoloquinazo-
line derivatives for which we might expect a wide spectrum
of bioresponses. Thus the active methylene in the methyl-
2-(2-thiocyanatoacetamido)benzoate (4) underwent nucleo-
philic addition reaction to the double bond of a variety of
arylidene malononitriles 8a-i via a Michael type addition
reaction [42], by refluxing in ethanol containing 10 mol %
of DABCO as catalyst to give a substance whose structure
was determined as thiazolo[3,2-a]quinazoline derivatives
9a-i, as established from the accurate mass determination,
1H-NMR and 13C-NMR. Moreover this structure was also
confirmed through the X-ray single crystal structure deter-
mination for 9a, 9c, 9d, 9f and 9h (cf. Figures 4, 5, 6, 7, 8







































Scheme 1 Synthesis of methyl-2-(2-thiocyanatoacetamido)benzoate (4) and the quinazoline derivative 5.
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http://journal.chemistrycentral.com/content/7/1/82times, easy workup, very good to excellent yields, and mild
reaction conditions make this Michael type addition reac-
tion followed by interamolecular cyclization both practical
and attractive. It is believed that initially the carbanion
which formed from 4 by the action of the base (B:) DABCO
undergoes nucleophilic addition to the double bond of the
arylidene malononitrile to form the adduct B followed by
losing one molecule of malononitrile and subsequent
interamolecular cyclization forming the thiazolidinone
ring via attack of the NH moiety at SCN, and finally
the thiazolo[3,2-a]quinazoline derivatives 9 was formed

















Scheme 2 The mechanistic pathway for compounds 5 and 10.another interamolecular cyclization. Also in order to con-
firm the above synthetic route we try to separate one of the
formed intermediates during the reaction and we success
to isolate the intermediate D [Ar = P-NO2C6H4] during the
preparation of 9e. The X-ray single crystal technique was
successfully employed in this study to confirm the potential
formation of the Z isomer during the preparation of 9 as a
sole isolable isomer product.
To optimize the reaction conditions, we systematically
investigated the reaction parameters using 4 and
benzylidene malononitriles 8a (Table 1). First, the effect











Figure 2 X-ray single crystal structure determined for compound 4 (CCDC 916665) [47].
Figure 1 X-ray single crystal structure determined for compound 3 (CCDC 916675) [46].
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Figure 3 X-ray single crystal structure determined for compound 5 (CCDC 916666) [48].
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bases, such as piperidine, morpholine, DBU, L-proline
and K2CO3 were less effective. Then we probed the
influence of different solvents on the reaction (entries
7–10). EtOH was found to be an effective solvent for
good results. CH3CN, DMF, dioxane and MeOH were
found to be less effective. With the optimized reaction
conditions in hand, we then explored the scope and gen-
erality of the synthesizing thiazolo[3,2-a]quinazoline de-
rivatives 9 via Michael type addition reaction followed
by the interamolecular cyclization. In addition we opti-
mized the quantity of the catalyst added, as we found
that 10 mol % of DABCO is the best quantity for the re-
action yield and we found that as the quantity of theFigure 4 X-ray single crystal structure determined for compound 9a (added catalyst increased or decreased the yield of the
reaction become lowered (Table 2).
In order to generate an alternative route for the synthe-
sis of the above thiazolo[3,2-a]quinazoline 9 we conduct
a reaction between methyl-2-(2-thiocyanatoacetamido)
benzoate (4) and aromatic aldehydes under the same reac-
tion conditions (EtOH, DABCO), but the structure of the
obtained product was identified as ethyl-2-[(4-oxo-3,4-
dihydroquinazolin-2-yl)thio]acetate (10) [45] and not as 9,
based on the spectrometric analyses and from the X-ray
single crystal structure determination (cf. Scheme 4,
Figure 9). Moreover refluxing 4 in ethanol only give 10 in
71% yields while refluxing it in ethanol containing
DABCO affords 10 in 99% yields so the presence of theCCDC 916667) [49].
Figure 5 X-ray single crystal structure determined for compound 9c (CCDC 916674) [50].
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http://journal.chemistrycentral.com/content/7/1/82DABCO enhance the reaction yield. Also the solvent has
an effect on the reaction product since refluxing 4 in
ethanol give 10 while refluxing 4 in methanol give 5
(cf. Scheme 2). Although the reaction between 10 and
arylidene malononitriles does not take place conducting
reaction between 10 and aromatic aldehydes in acetic acid
containing sodium acetate afforded two regioselectively
products with identical percentage yield as indicated from
the 1H-NMR spectra, these two products were identified
as 9 and 11 respectively, this mean that the regioselectively
for this reaction is 50% for each route of cyclization.
The obtained ethyl-2-[(4-oxo-3,4-dihydroquinazolin-2-yl)
thio]acetate (10) seem interesting precursor for theFigure 6 X-ray single crystal structure determined for compound 9d (synthesis of a variety of a novel quinazoline and fused
quinazoline derivatives. Thus reacting 10 with dimethyl-
formamide dimethylacetal (DMF-DMA) yield also two
regioselectively products with identical percentage yield,
these two products were identified as 12 and 13 respect-
ively, the structure of these two products was confirmed
via the X-ray single crystal determination (cf. Scheme 5,
Figures 10, 11).
Moreover reacting 10 with hydrazine hydrate in
refluxing ethanol affording the corresponding hydrazide
derivatives 14 which on reaction with aromatic alde-
hydes affording the corresponding condensation product
15, also 10 reacts with primary aromatic amines toCCDC 916671) [51].
Figure 7 X-ray single crystal structure determined for compound 9f (CCDC 916670) [52].
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http://journal.chemistrycentral.com/content/7/1/82afford the corresponding acetamide derivatives 16. In
addition the triazolylquinazoline derivative 18 was
formed via reaction of the hydrazide derivatives 14 with
carbon disulfide in alcoholic potassium hydroxide to
form 17 which on reaction with hydrazine hydrate af-
fords the triazole 18. Moreover the quinazoline ethyl
ester 10 was reacted with ethanol amine to afford




Melting points were recorded on a Griffin melting point
apparatus and are reported uncorrected. IR spectra were
recorded using KBr disks using a Perkin-Elmer System
2000 FT-IR spectrophotometer. 1H-NMR (400 MHz) or
(600 MHz) and 13C-NMR (100 MHz) or (150 MHz)Figure 8 X-ray single crystal structure determined for compound 9h (spectra were recorded at 25°C in CDCl3 or DMSO-d6 as
solvent with TMS as internal standard on a Bruker DPX
400 or 600 super-conducting NMR spectrometer. Chem-
ical shifts are reported in ppm. Mass spectra and HRMS
were measured using a high resolution GC-MS (DFS)
thermo spectrometers with EI (70 EV). Follow up of the
reactions and checking homogeneity of the prepared
compounds was made by thin layer chromatography
(TLC). The crystal structures were determined by a
Rigaku R-AXIS RAPID diffractometer and Bruker X8
Prospector and the data were collected at a temperature
of 20 ± 1°C to a maximum 2θ value of 55.0° or 66.61°
using the ω scanning technique. The structure was
solved either by direct method using SHELXS-97
(Sheldrick, 2008) and refined by Full-matrix least-
squares on F2. The non-hydrogen atoms were refined
anisotropically. Data were corrected for absorption
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Scheme 3 Synthesis and the mechanistic pathway for the thiazolo[3,2-a]quinazoline derivatives 9.
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http://journal.chemistrycentral.com/content/7/1/82charge flipping method and expanded using Fourier
techniques. The non-hydrogen atoms were refined an-
isotropically. Hydrogen atoms were refined using the
riding model
Methyl-4-(2-chloroacetamido)benzoate (3)
A solution of methyl anthranilate (1) (10 mmol, 1.52 g)
and chloroacetyl chloride (2) (1.36 g, 12 mmol) in
chloroform (50 mL) was refluxed in the presence of
K2CO3 (2.1 g, 15 mmole) for 3 h. Then the solvent was
removed in vacuo and the residue was stirred with water(100 mL) and filtered. The solid product is then washed
with 5% NaHCO3 solution and subsequently with water.
The crude product was dried and recrystallized from
EtOH as white crystals, yield: 96%, m.p. 90-91°C; IR
(KBr): v /cm−1 3225 (NH), 1699, 1679 (2CO); 1H-NMR
(DMSO-d6): δ = 3.89 (s, 3H, CH3), 4.45 (s, 2H, CH2),
7.25 (t, J = 8.0 Hz, 1H , Ar-H), 7.66 (t, J = 8.0 Hz, 1H,
Ar-H), 7.98 (d, J = 8.0 Hz, 1H, Ar-H), 8.40 (d, J = 8.0
Hz, 1H, Ar-H) and 11.34 ppm (s, 1H, NH); 13C-NMR
(DMSO-d6): δ = 43.3 (CH2), 52.5 (CH3), 116.8, 120.4,
123.7, 130.7, 134.2, 139.2, 165.1 and 167.4 ppm (Ar-C
Table 1 Optimization of conditions of the synthesis 9a a
Entry a Base Solvent Time(min) Yield (%)
1 DABCO EtOH 5 81
2 piperidine EtOH 30 67
3 morpholine EtOH 25 61
4 DBU EtOH 15 55
5 L-proline EtOH 40 69
6 K2CO3 EtOH 60 none
7 DABCO CH3CN 15 35
8 DABCO DMF 5 46
9 DABCO Dioxane 5 51
10 DABCO MeOH 5 68
a Reaction conditions: methyl-2-(2-thiocyanatoacetamido)benzoate (4) (5
mmol), benzylidene malononitriles 8a (5 mmol), and base (10 mol %) in
solvent (25 mL) under reflux for the given time.
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http://journal.chemistrycentral.com/content/7/1/82and CO); MS (EI): m/z (%) 229 (M++2, 14.12), 228
(M++1, 7.85), 227 (M+, 43.55); HRMS (EI): m/z calcd.
for C10H10
35ClNO3 (M
+) 227.0343, found 227.0343. Crys-
tal data: C10H10ClNO3, M = 227.65, monoclinic,
a = 12.8980(12) Å, b = 4.6089(4) Å, c = 18.2514(15) Å, V
= 1031.08(16) Å3, α = γ = 90.00°, β = 108.133(5), space
group: P 1 21/c 1, Z = 4, Dcalc = 1.466 Mg cm
−3 , No. of
reflections measured 4589, 2θmax = 66.59°, R1 = 0.034.
Figure 1 illustrates the structure as determined. Full data
can be obtained on request from the CCDC [46].
Methyl-2-(2-thiocyanatoacetamido)benzoate (4)
A solution of methyl-4-(2-chloroacetamido)benzoate (3)
(2.27 g, 10 mmol) and ammonium thiocyanate (15
mmol) in acetone or absolute methanol (30 mL) was
refluxed for 6 h and allowed to cool. The formed pre-
cipitate was filtered off, washed with water and then
recrystallised from MeOH as white crystals, yield: 92%,
m.p. 109–110°C; IR (KBr): v /cm−1 3241 (NH), 2155
(SCN), 1737, 1698 (2CO); 1H-NMR (DMSO-d6): δ =
3.87 (s, 3H, CH3), 4.24 (s, 2H, CH2), 7.25 (t, J = 8.0 Hz,
1H, Ar-H), 7.63 (t, J = 8.0 Hz, 1H, Ar-H), 7.91 (d, J = 8.0
Hz, 1H, Ar-H), 8.16 (d, J = 8.0 Hz, 1H, Ar-H) and 10.93
ppm (s, 1H, NH); 13C-NMR (DMSO-d6): δ = 37.4 (CH2),Table 2 Optimization mol % of DABCO during the
synthesis 9a









9 70 4552.5 (CH3), 112.7 (SCN), 118.8, 121.7, 124.1, 130.6,
133.9, 138.4, 164.6 and 167.2 ppm (Ar-C and CO); MS
(EI): m/z (%) 251 (M++1, 10.42), 250 (M+, 34.91); HRMS
(EI): m/z calcd. for C11H10N2O3S (M
+) 250.0406, found
250.0407. Crystal data: C11H10N2O3S, M = 250.28, tri-
clinic, a = 6.7349(6) Å, b = 8.3058(9) Å, c = 10.3398(8)
Å, V = 558.19(9) Å3, α =86.526(6), β = 85.256(6)°, γ =
75.747(6), space group: P-1 (#2), Z = 2, Dcalc = 1.489 Mg
cm−3, No. of reflections measured 2518, 2θmax =54.9°,
R1 = 0.033. Figure 2 illustrates the structure as deter-
mined. Full data can be obtained on request from the
CCDC [47].
Methyl-2-(4-oxo-3,4-dihydroquinazolin-2-ylthio)acetate (5)
A solution of methyl-4-(2-chloroacetamido)benzoate (3)
(2.27 g, 10 mmol) and ammonium thiocyanate (15 mmol)
in methanol (30 mL) was refluxed for 12 h, or refluxing 4
in MeOH for 6h then the reaction mixture was allowed to
cool down to room temperature. The formed precipitate
was filtered off, washed with water and then recrystallised
from MeOH as white crystals, yield: 88%, m.p. 191–192°C;
IR (KBr): v/cm−1 3172 (NH), 1737, 1686 (2CO); 1H-NMR
(DMSO-d6): δ = 3.69 (s, 3H, CH3), 4.11 (s, 2H, CH2),
7.41-7.45 (m, 2H , Ar-H), 7.76 (t, J = 7.6 Hz, 1H, Ar-H),
8.03 (d, J = 7.6 Hz, 1H, Ar-H), 12.72 ppm (s, 1H, NH);
13C-NMR (DMSO-d6): δ = 32.1 (CH2), 52.4 (CH3), 119.8,
125.8, 125.9, 126.0, 134.7, 148.1, 154.6, 161.1 and 169.0
ppm (Ar-C and CO); MS (EI): m/z (%) 251 (M++1, 7.24),
250 (M+, 32.55); HRMS (EI): m/z calcd. for C11H10N2O3S
(M+) 250.0406, found 250.0406. Crystal data:
C11H10N2O3S, M = 250.28, orthorhombic, a = 17.863(2)
Å, b = 13.1670(7) Å, c = 4.6272(2) Å, V = 1088.3(1) Å3,
α = β = γ = 90.0°, space group: Pna21 (#33), Z = 4, Dcalc =
1.527 Mg cm−3, No. of reflections measured 2058, 2θmax =
54.80°, R1 = 0.0384. Figure 3 illustrates the structure as de-
termined. Full data can be obtained on request from the
CCDC [48].
General procedure for the synthesis of thiazolo[3,2-a]-
quinazoline derivatives 9a–i
Independent mixtures of methyl-2-(2-thiocyanatoacetamido)-
benzoate (4) (1.25 g, 5 mmol) and the appropriate arylidene
malononitrile 8a-i (5 mmol) in ethanol (25 mL) containing
DABCO (0.11 g, 10 mol %) were stirred at reflux for 5 min.
Then, the reaction mixtures were allowed to cool down to
room temperature. The solid which formed was collected
by filtration, washed with hot ethanol, and recrystallized
from the appropriate solvent to afford 9a–i respectively, as
pure substances.
(Z)-2-Benzylidene-2H-thiazolo[3,2-a]quinazoline-1,5-dione (9a)
Recrystallized from an EtOH/ dioxane (1:1) mixture as
canary yellow crystals, yield: (81%), m.p. 236–237°C; IR














































Scheme 4 Reaction of 10 with aromatic aldehydes.
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http://journal.chemistrycentral.com/content/7/1/82δ = 7.54-7.68 (m, 4H, Ar-H), 7.76 (d, J = 7.6 Hz, 2H,
Ar-H), 7.94 (t, J = 8.0 Hz, 1H, Ar-H), 8.15 (d, J = 8.0 Hz,
1H, Ar-H), 8.17 (s, 1H, olefinic CH) and 8.98 ppm (d, J
= 8.0 Hz, 1H, Ar-H); 13C-NMR (DMSO-d6): δ = 116.3,
117.7, 118.8, 127.9, 127.9, 129.6, 130.5, 131.3, 132.7,
134.5, 135.8, 137.1, 164.2, 164.3 and 165.2 ppm (Ar-CFigure 9 X-ray single crystal structure determined for compound 10 (and CO); MS (EI): m/z (%) 307 (M++1, 19.44), 306 (M+,
100); HRMS (EI): m/z calcd. for C17H10N2O2S (M
+)
306.0457, found 306.0457. Crystal data: C17H10N2O2S,
M = 306.34, triclinic, a = 6.391(5) Å, b = 8.650(7) Å, c =
12.77(1)Å, V = 676.2(9) Å3, α =76.57(2), β =87.89(1), γ =





























Scheme 5 Reaction of 10 with dimethylformamide dimethylacetal (DMF-DMA).
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R1 = 0.0458. Figure 4 illustrates the structure as deter-




Recrystallized from dioxane as pale yellow crystals, yield:
(79%), m.p. 253–254°C; IR (KBr): v /cm−1 1726, 1681
(2CO); 1H-NMR (DMSO-d6): δ = 2.40 (s, 3H, CH3), 7.40
(d, J = 7.6 Hz, 2H, Ar-H), 7.59-7.64 (m, 3H, Ar-H), 7.90
(t, J = 8.0 Hz, 1H, Ar-H), 8.10 (s, 1H, olefinic CH), 8.16
(d, J = 8.0 Hz, 1H, Ar-H) and 8.97 ppm (d, J = 8.0 Hz,
1H, Ar-H); 13C-NMR (DMSO-d6): δ = 21.2 (CH3), 116.3,
117.5, 117.8, 127.8, 127.9, 130.1, 130.2, 130.6, 134.5,
135.9, 137.1, 141.8, 164.2, 164.4 and 165.3 ppm (Ar-C
and CO); MS (EI): m/z (%) 321 (M++1, 17.99), 320Figure 10 X-ray single crystal structure determined for compound 12(M+, 100); HRMS (EI): m/z calcd. for C18H12N2O2S
(M+) 320.0613, found 320.0614.
(Z)-2-(4-Methoxybenzylidene)-2H-thiazolo[3,2-a]quinazoline-
1,5-dione (9c)
Recrystallized from dioxane as yellow crystals, yield: (83%),
m.p. 261–262 °C; IR (KBr): v/cm−1 1721, 1676 (2CO); 1H-
NMR (DMSO-d6): δ = 3.87 (s, 2H, OCH3), 7.18 (d, J = 7.6
Hz, 2H, Ar-H), 7.66 (t, J = 8.0 Hz, 1H, Ar-H), 7.75 (d, J =
7.6 Hz, 2H, Ar-H), 7.93 (t, J = 8.0 Hz, 1H, Ar-H), 8.11
(s, 1H, olefinic CH), 8.17 (d, J = 8.0 Hz, 1H, Ar-H) and 9.02
ppm (d, J = 8.0 Hz, 1H, Ar-H); 13C-NMR (DMSO-d6 at
80°C ): δ = 56.2 (OCH3), 115.8, 116.8, 118.6, 126.0, 128.2,
128.4, 130.9, 133.1, 134.6, 136.8, 137.6, 162.5, 164.2, 164.6
and 165.4 ppm (Ar-C and CO); MS (EI): m/z (%) 337
(M++1, 16.96), 336 (M+, 100); HRMS (EI): m/z calcd. for
C18H12N2O3S (M
+) 336.0563, found 336.0563. Crystal data:(CCDC 916668) [55].
Figure 11 X-ray single crystal structure determined for compound 13 (CCDC 916669) [56].
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http://journal.chemistrycentral.com/content/7/1/82C18H12N2O3S, M = 336.37, monoclinic, a = 8.1837(3) Å,
b = 15.2696(4) Å, c = 24.0028(7) Å, V = 2996.81(16) Å3,
α = γ = 90.00°, β = 92.397(2)°, space group: P 1 21/c 1, Z =
4, Dcalc = 1.491 Mg cm
−3 , No. of reflections measured
5296, 2θmax = 66.73 °, R1 = 0.0339. Figure 5 illustrates the
structure as determined. Full data can be obtained on











































Scheme 6 Synthesis of some quinazoline derivatives.(Z)-2-(4-Chlorobenzylidene)-2H-thiazolo[3,2-a]quinazoline-
1,5-dione (9d)
Recrystallized from dioxane as yellow crystals, yield:
(85%), m.p. 279–280°C; IR (KBr): v /cm−1 1720, 1692
(2CO); 1H-NMR (DMSO-d6): δ = 7.63-7.66 (m, 3H,
Ar-H), 7.75 (d, J = 8.4 Hz, 2H, Ar-H), 7.92 (t, J = 8.4 Hz,
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http://journal.chemistrycentral.com/content/7/1/821H, Ar-H) and 8.97 ppm (d, J = 8.4 Hz, 1H, Ar-H); 13C-
NMR (DMSO-d6 at 80°C ): δ = 116.3, 117.7, 119.6,
127.9, 129.5, 129.6, 131.6, 132.10, 134.4, 134.5, 135.8,
137.0, 164.0, 164.2 and 165.2 ppm (Ar-C and CO); MS
(EI): m/z (%) 341 (M++1, 20.28), 340 (M+, 100); HRMS
(EI): m/z calcd. for C17H9
35ClN2O2S (M
+) 340.0067,
found 340.0066. Crystal data: C17H9ClN2O2S, M =
340.78, monoclinic, a = 3.8563(7) Å, b = 12.784(2) Å,
c = 28.101 (5)Å, V = 1384.9(4)Å3, α = γ = 90.00°, β =
91.456(7)°, space group: P21/c (#14), Z = 4, Dcalc = 1.634
Mg cm−3, No. of reflections measured 7510, 2θmax =
50.1°, R1 = 0.0935. Figure 6 illustrates the structure as




Recrystallized from dioxane/DMF (1:1) mixture as yel-
low crystals: (87%), m.p. 296–297°C; IR (KBr): v /cm−1
1716, 1675 (2CO); 1H-NMR (DMSO-d6): δ = 7.67 (t, J =
8.4 Hz, 1H, Ar-H), 7.96 (t, J = 8.4 Hz, 1H, Ar-H), 8.01
(d, J = 8.4 Hz, 2H, Ar-H), 8.19 (d, J = 8.4 Hz, 1H, Ar-H),
8.26 (s, 1H, olefinic CH), 8.39 (d, J = 8.4 Hz, 2H, Ar-H)
and 8.98 ppm (d, J = 8.0 Hz, 1H, Ar-H); 13C-NMR
(DMSO-d6 at 80°C ): δ = 116.3, 117.6, 123.3, 124.5,
128.0, 128.0, 131.3, 132.8, 134.7, 136.9, 138.8, 147.8,
163.8, 163.9 and 165.1 ppm (Ar-C and CO); MS (EI):
m/z (%) 352 (M++1, 19.99), 351 (M+, 100); HRMS





Recrystallized from dioxane/DMF (1:2) mixture as or-
ange crystals: (82%), m.p. 238–239°C; IR (KBr): v/cm−1
1728, 1673 (2CO); 1H-NMR (DMSO-d6): δ = 7.66 (t, J =
7.8 Hz, 1H, Ar-H), 7.89 (t, J = 7.8 Hz, 1H, Ar-H), 7.92 (t,
J = 8.4 Hz, 1H, Ar-H), 8.13 (d, J = 7.8 Hz, 1H, Ar-H),
8.19 (d, J = 8.4 Hz, 1H, Ar-H), 8.29 (s, 1H, olefinic CH),
8.33 (d, J = 8.4 Hz, 1H, Ar-H), 8.53 (s, 1H, Ar-H), and
8.96 ppm (d, J = 7.8 Hz, 1H, Ar-H); 13C-NMR (DMSO-
d6 at 80°C ): δ = 116.3, 117.9, 122.1, 124.7, 124.9, 127.9,
128.0, 131.0, 133.4, 134.4, 134.5, 135.3, 136.9, 148.6,
163.3, 163.7 and 164.9 ppm (Ar-C and CO); MS (EI): m/
z (%) 352 (M++1, 17.78), 351 (M+, 100); HRMS (EI): m/z
calcd. for C17H9N3O4S (M
+) 351.0308, found 351.0308.
Crystal data: C17H9N3O4S, M = 351.34, monoclinic, a =
8.2228(6) Å, b = 27.550(2) Å, c = 6.7703(5) Å, V =
1449.3(2) Å3, α = γ = 90.00°, β = 109.096(7)°, space
group: P21/c (#14), Z = 4, Dcalc = 1.610 Mg cm
−3 , No.
of reflections measured 9355, 2θmax = 52.7°, R1 =
0.0482. Figure 7 illustrates the structure as deter-
mined. Full data can be obtained on request from the
CCDC [52].(Z)-2-[4-(Dimethylamino)benzylidene]-2H-thiazolo[3,2-a]-
quinazoline-1,5-dione (9g)
Recrystallized from DMF as deep orange crystals: (78%),
m.p. 289–290 °C; IR (KBr): v/cm−1 1707, 1671 (2CO); 1H-
NMR (DMSO-d6): δ = 3.08 (s, 6H, 2CH3), 6.99 (d, J = 9.0
Hz, 2H, Ar-H), 7.58 (d, J = 9.0 Hz, 2H, Ar-H), 7.63 (t, J =
8.4 Hz, 1H, Ar-H), 7.88 (t, J = 8.4 Hz, 1H, Ar-H), 8.02
(s, 1H, olefinic CH), 8.18 (d, J = 8.4 Hz, 1H, Ar-H) and
9.04 ppm (d, J = 8.4 Hz, 1H, Ar-H); 13C-NMR (DMSO-d6
at 80°C ): δ = 66.4 (2CH3), 110.0, 112.3, 116.3, 118.1,
119.8, 127.5, 127.8, 132.9, 133.9, 137.2, 137.5, 152.4, 163.8,
164.3 and 165.1 ppm (Ar-C and CO); MS (EI): m/z (%)
350 (M++1, 23.97), 349 (M+, 100); HRMS (EI): m/z calcd.
for C19H15N3O2S (M
+) 349.0879, found 349.0878.
(Z)-2-(Thiophen-2-ylmethylene)-2H-thiazolo[3,2-a]-
quinazoline-1,5-dione (9h)
Recrystallized from DMF as pale orange crystals: (76%),
m.p. 269–270°C; IR (KBr): v /cm−1 1705, 1671 (2CO);
1H-NMR (DMSO-d6): δ = 7.36 (t, J = 6.6 Hz, 1H, Ar-H),
7.65 (t, J = 8.4 Hz, 1H, Ar-H), 7.79 (d, J = 6.6 Hz, 1H,
Ar-H), 7.90 (t, J = 8.4 Hz, 1H, Ar-H), 8.09 (d, J = 6.6 Hz,
1H, Ar-H), 8.18 (d, J = 8.4 Hz, 1H, Ar-H), 8.39 (s, 1H,
olefinic CH) and 8.99 ppm (d, J = 8.4 Hz, 1H, Ar-H);
13C-NMR (DMSO-d6 at 80°C ): δ = 116.1, 116.3, 117.9,
127.7, 127.9, 129.0, 129.3, 134.2, 134.2, 135.5, 137.1,
137.1, 163.3, 163.8 and 165.0 ppm (Ar-C and CO); MS
(EI): m/z (%) 313 (M++1, 19.27), 312 (M+, 100); HRMS
(EI): m/z calcd. for C15H8N2O2S2 (M
+) 312.0021, found
312.0021. Crystal data: C15H8N2O2S2, M = 312.37,
monoclinic, a = 3.89160(10) Å, b = 27.5592(8) Å, c =
12.1569(3) Å, V = 1293.43(6) Å3, α = γ = 90.00°, β =
97.2380(10)°, space group: P 1 21/n 1, Z = 4, Dcalc =
1.604 Mg cm−3 , No. of reflections measured 8288,
2θmax = 66.65°, R1 = 0.0320. Figure 8 illustrates the
structure as determined. Full data can be obtained on re-
quest from the CCDC [53].
(Z)-2-(2,4-Dimethoxybenzylidene)-2H-thiazolo[3,2-a]-
quinazoline-1,5-dione (9i)
Recrystallized from DMF as yellow crystals, yield: (74%),
m.p. 254–255 °C; IR (KBr): v /cm−1 1712, 1685 (2CO);
1H-NMR (DMSO-d6): δ = 3.90 (s, 3H, OCH3), 3.98
(s, 3H, OCH3), 6.76 (d, J = 9.0 Hz, 2H, Ar-H), 7.54-7.64
(m, 2H, Ar-H), 7.90 (s, 1H, Ar-H), 8.18 (d, J = 8.4 Hz,
1H, Ar-H), 8.25 (s, 1H, olefinic CH) and 9.00 ppm (d, J
= 8.4 Hz, 1H, Ar-H); MS (EI): m/z (%) 367 (M++1,
24.15), 366 (M+, 100); HRMS (EI): m/z calcd. for
C19H14N2O4S (M
+) 366.0668, found 336.0668.
(Z)-Methyl-2-[5-(4-nitrobenzylidene)-2-imino-4-oxothi-
azolidin-3-yl]benzoate (D [Ar = P-NO2C6 H4])
A mixture of methyl-2-(2-thiocyanatoacetamido)benzo-
ate (4) (1.25 g, 5 mmol) and 4-nitrobenzylidene
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containing DABCO (0.11 g, 10 mol %) were stirred at re-
flux for just dissolving the reaction mixture and the
product began to separated from the reaction approxi-
mately after 2 min. Then, the reaction mixture was fil-
tered off while it hot, the precipitate is 9 and the filtrate
containing the intermediate D which allowed to cooled
to room temperature. The precipitate which formed was
filtered off and washed with water and recrystallized
from dioxane as pale yellow crystals: m.p. 282–283°C; IR
(KBr): v /cm−1 3267 (NH), 1717, 1705 (2CO); 1H-NMR
(DMSO-d6): δ = 3.74 (s, 3H, CH3), 7.55 (d, J = 8.0 Hz,
1H, Ar-H), 7.66 (t, J = 8.0 Hz, 1H, Ar-H), 7.80-7.83
(m, 2H, 1 Ar-H and olefinic CH), 7.88 (d, J = 8.4 Hz, 2H,
Ar-H), 8.07 (d, J = 8.0 Hz, 1H, Ar-H), 8.40 (d, J = 8.4
Hz, 2H, Ar-H) and 9.97 ppm (s, 1H, NH); 13C-NMR
(DMSO-d6 at 80°C ): δ = 66.3 (CH3), 124.3, 125.8, 127.8,
127.8, 129.5, 130.6, 131.0, 131.1, 133.6, 134.5, 139.9,
147.1, 151.9, 164.5 and 165.3 ppm (Ar-C and CO); MS
(EI): m/z (%) 384 (M++1, 16.25), 383 (M+, 4.95); HRMS




A solution of methyl-2-(2-thiocyanatoacetamido)benzo-
ate (4) (2.50 g, 10 mmol) in ethanol (40 mL) containing
DABCO (0.11 g, 10 mol %), was refluxed for 3 h and
allowed to cool. The formed precipitate was filtered off,
washed with water and then recrystallised from EtOH
as white crystals, yield: (99%) {lit. [45] (72%)}, m.p.
184–185°C {lit. [45], mp 179–180°C (MeOH)}; IR (KBr):
v/cm−1 3167 (NH), 1728, 1697 (2CO); 1H-NMR (DMSO-
d6): δ = 1.20 (t, 3H, J = 7.2 Hz, CH3CH2), 4.08 (s, 2H,
CH2), 4.14 (q, 2H, J = 7.2 Hz, CH3CH2), 7.40-7.44
(m, 2H , Ar-H), 7.75 (t, J = 8.0 Hz, 1H, Ar-H), 8.03
(d, J = 8.0 Hz, 1H, Ar-H) and 12.71 ppm (s, 1H, NH);
13C-NMR (DMSO-d6): δ = 14.1 ( CH3), 32.3 (CH2), 61.1
(CH2), 119.8, 125.8, 125.9, 126.1, 134.3, 148.1, 154.7,
161.1 and 168.4 ppm (Ar-C and CO); MS (EI): m/z (%)
265 (M++1, 14.25), 264 (M+, 87.44); HRMS (EI): m/z
calcd. for C12H12N2O3S (M
+) 264.0563, found 264.0563.
Crystal data: C12H12N2O3S, M = 264.31, orthorhombic,
a = 10.1158(2) Å, b = 7.6750(2) Å, c = 31.3650(6) Å, V =
2435.14(9) Å3, α = β = γ = 90.0°, space group: P b c a,
Z = 8, Dcalc = 1.442 Mg cm
−3, No. of reflections mea-
sured 8543, θmax = 66.55°, R1 = 0.034. Figure 9 illustrates
the structure as determined. Full data can be obtained
on request from the CCDC [54].
General procedure for the reaction of 10 with aromatic
aldehydes
A mixture of ethyl-2-[(4-oxo-3,4,-dihydroquinazolin-2-
yl)thio]acetate (10) (1.32 g, 5 mmol) and the appropriate
arylaldehyde (5 mmol) in acetic acid (25 mL) containinganhydrous sodium acetate (0.84 g, 10 mmol) was
refluxed for 5 h. The reaction mixture was then cooled
to room temperature. The precipitate which formed was
filtered off and washed with water and the resulting
crude product was purified by recrystallization from the
appropriate solvent to afford a mixture from 9 and 11 in
ratio 1:1 as illustrated from the 1H-NMR spectra. We
cannot separate the mixtures by crystallization or by
long column chromatography due to the difficult solu-
bility of the mixtures so the reported spectral data are
for both products (cf. Additional file 1).
(Z)-2-(4-Methylbenzylidene)-2H-thiazolo[2,3-b]quinazoline-
3,5-dione (11a) and 9b
Recrystallized from dioxane as pale yellow crystals, yield:
(38% 9b + 38% 11a), m.p. (for mixture) 218–220°C; IR
(KBr): v /cm−1 1766, 1727, 1704, 1678 (4CO); 1H-NMR
(DMSO-d6): δ = 2.37 (s, 6H, 2CH3), 7.38-7.41 (m, 4H,
Ar-H), 7.54 (t, J = 7.6 Hz, 1H, Ar-H), 7.58-7.67 (m, 6H,
Ar-H), 7.86 (t, J = 7.6 Hz, 1H, Ar-H), 7.93 (t, J = 8.0 Hz,
1H, Ar-H), 7.96 (s, 1H, olefinic CH for 11a), 8.12 (s, 1H,
olefinic CH for 9b), 8.17 (t, J = 7.6 Hz, 2H, Ar-H) and
8.98 ppm (d, J = 8.0 Hz, 1H, Ar-H); MS (EI): m/z (%)
321(M++1, 21.55), 320 (M+, 100); HRMS (EI): m/z calcd.
for C18H12N2O2S (M
+) 320.0613, found 320.0614.
(Z)-2-(4-Methoxybenzylidene)-2H-thiazolo[2,3-b]-
quinazoline-3,5-dione (11b) and 9c
Recrysta- llized from dioxane as yellow crystals, yield:
(35% 9c + 35% 11b), m.p. (for mixture) 206–208°C; IR
(KBr): v /cm−1 1765, 1719, 1704, 1683 (2CO); 1H-NMR
(DMSO-d6): δ = 3.84 (s, 6H, 2OCH3), 7.12-7.15 (m, 4H,
Ar-H), 7.53 (t, J = 8.0 Hz, 1H, Ar-H), 7.60 (t, J = 7.6 Hz,
1H, Ar-H), 7.64-7.67 (m, 3H, Ar-H), 7.71 (d, J = 8.4 Hz,
2H, Ar-H), 7.85 (t, J = 8.0 Hz, 1H, Ar-H), 7.91 (t, J = 8.4
Hz, 1H, Ar-H), 7.95 (s, 1H, olefinic CH for 11b), 8.10
(s, 1H, olefinic CH for 9c), 8.14 (t, J = 7.6 Hz, 2H, Ar-H)
and 8.98 ppm (d, J = 8.4 Hz, 1H, Ar-H); MS (EI): m/z
(%) 337 (M++1, 22.15), 336 (M+, 100); HRMS (EI): m/z
calcd. for C18H12N2O3S (M
+) 336.0563, found 336.0562.
(Z)-2-(4-Chlorobenzylidene)-2H-thiazolo[2,3-b]quinazoline-
3,5-dione (11c) and 9d
Recrystallized from dioxane as pale yellow crystals, yield:
(34% 9d + 34% 11c), m.p. (for mixture) 250–252°C; IR
(KBr): v /cm−1 1765 (br), 1698, 1679 (4CO); 1H-NMR
(DMSO-d6): δ = 7.52-7.58 (m, 2H, Ar-H), 7.61-7.69
(m, 6H, Ar-H), 7.74 (d, J = 8.4 Hz, 2H, Ar-H), 7.79
(d, J = 8.8 Hz, 2H, Ar-H), 7.88 (t, J = 8.0 Hz, 1H, Ar-H),
7.95 (t, J = 8.4 Hz, 1H, Ar-H), 8.02 (s, 1H, olefinic CH
for11c), 8.16-8.20 (m, 3H, 2 Ar-H and olefinic CH for 9d)
and 8.98 ppm (d, J = 8.4 Hz, 1H, Ar-H); MS (EI): m/z (%)
342 (M++2, 34.66), 341 (M++1, 1985), 340 (M+, 100);
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+) 340.0067,
found 340.0067.
General procedure for the synthesis of compounds
12 and 13
A solution of ethyl-2-[(4-oxo-3,4,-dihydroquinazolin-2-yl)
thio]acetate (10) (2.64 g, 10 mmol), N,N-dimethylfor-
mamide dimethylacetal (DMF-DMA) (1.2 g, 10 mmol) in
ethanol (30 mL) were stirred at reflux for 6 h. The sepa-
rated solid product obtained on standing at room
temperature was collected by filtration, washed by EtOH
and recrystallized from EtOH the dissolved product was
identified as 12 and the undissolved one recrystalized
from DMSO and identified as 13.
5-Oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid ethyl
ester (12)
Yield: 43%, m.p. 293–294°C; IR (KBr): v /cm−1 1727,
1691 (2CO); 1H-NMR (DMSO-d6): δ = 1.34 (t, 3H, J =
7.2 Hz, CH3CH2), 4.37 (q, 2H, J = 7.2 Hz, CH3CH2), 7.55
(t, J = 8.0 Hz, 1H, Ar-H), 7.66 (d, J = 8.0 Hz, 1H, Ar-H),
7.92 (t, J = 8.0 Hz, 1H, Ar-H), 8.25 (d, J = 8.0 Hz, 1H,
Ar-H) and 8.44ppm (s, 1H, thiazole H3); m/z (%) 275
(M++1, 16.46), 274 (M+, 100); HRMS (EI): m/z calcd. for
C13H10N2O3S (M
+) 274.0406, found 274.0406. Crystal
data: C13H10N2O3S, M = 274.30, monolinic, a = 10.555
(4) Å, b = 25.556(7) Å, c = 9.115(3) Å, V = 2455(2) Å3,
α = γ = 90.00°, β =93.191(7)o, space group: C2/c (#15),
Z = 8, Dcalc = 1.484 Mg cm
−3 , No. of reflections mea-
sured 2482, 2θmax = 52.70°, R1 = 0.0666. Figure 10 illus-
trates the structure as determined. Full data can be
obtained on request from the CCDC [55].
(Z)-2-[(Dimethylamino)methylene]-2H-thiazolo[3,2-a]-
quinazoline-1,5-dione (13)
Yield: 43%, m.p. 277–278°C; IR (KBr): v /cm−1 1706,
1692 (2CO); 1H-NMR (DMSO-d6): δ = 3.29 (s, 6H,
2CH3), 7.61 (t, J = 7.6 Hz, 1H, Ar-H), 7.85 (t, J = 7.6 Hz,
1H, Ar-H), 8.08 (s, 1H, olefinic CH), 8.15 (d, J = 7.6 Hz,
1H, Ar-H) and 9.21 ppm (d, J = 7.6 Hz, 1H, Ar-H); m/z
(%) 274 (M++1, 19.88), 273 (M+, 100); HRMS (EI): m/z
calcd. for C13H11N3O2S (M
+) 273.0566, found 273.0567.
Crystal data: C13H11N3O2S, M = 273.32, monolinic, a =
23.074(2) Å, b = 10.1009(7) Å, c = 13.896(1)Å, V = 676.2
(9) Å3, α = γ = 90.00°, β =105.058(8)o, space group: C2/c
(#15), Z = 8, Dcalc = 1.493Mg cm
−3 , No. of reflections
measured 3557, 2θmax = 54.90°, R1= 0.0381. Figure 11
illustrates the structure as determined. Full data can be
obtained on request from the CCDC [56].
2-[(4-Oxo-3,4-dihydroquinazolin-2-yl)thio]acetohydrazide (14)
A solution of ethyl-2-[(4-oxo-3,4,-dihydroquinazolin-2-
yl)thio]acetate (10) (2.64 g, 10 mmol), hydrazine hydrate
99% (0.75 g, 15 mmol) in absolute ethanol (30 mL) wasstirred at reflux for 2 h. The separated solid product
from the reaction mixture was collected by filtration,
washed by water and recrystallized from EtOH as white
crystals, yield: 92%, m.p. above 300°C; IR (KBr): v/cm−1
3432, 3305, 3295, 3237 (2NH and NH2), 1685, 1651
(2CO); 1H-NMR (DMSO-d6): δ = 3.93 (s, 2H, CH2), 4.34
(br, 2H, NH2, D2O exchangeable ), 7.43 (t, J = 8.0 Hz,
1H, Ar-H), 7.53 (d, J = 8.0 Hz, 1H, Ar-H), 7.77 (t, J = 8.0
Hz, 1H, Ar-H), 8.03 (d, J = 8.0 Hz, 1H, Ar-H), 9.37 (br,
1H, NH) and 12.71 ppm (s, 1H, NH); 13C-NMR
(DMSO-d6): δ = 32.1 (CH2), 119.9, 125.7, 126.0, 134.6,
148.2, 155.2, 161.2, 166.5 and 171.1 ppm (Ar-C and
CO); MS (EI): m/z (%) 251 (M++1, 4.22), 250 (M+,





A solution of the acetohydrazide 14 (1.25 g, 5 mmol), 4-
chlorobenzaldehyde (0.70 g, 5 mmol) in ethanol (25 mL)
containing DABCO (0.11 g, 10 mol %) was stirred at re-
flux for 5 h. The separated solid product obtained on
standing at room temperature was collected by filtration,
washed by EtOH and recrystallized from dioxane/DMF
(1:1) mixture as white crystals, yield: 77%, m.p. 234–235
°C; IR (KBr): v/cm−1 3438, 3173 (2NH), 1673 (br 2CO);
1H-NMR (DMSO-d6): δ = 3.57 (s, 2H, CH2), 7.40-7.52
(m, 4H, Ar-H), 7.72-7.76 (m, 3H, Ar-H), 8.02-8.05
(m, 2H, 1Ar-H and amidine CH), 11.74 (br, 1H, NH)
and 12.70 ppm (s, 1H, NH); 13C-NMR (DMSO-d6): δ =
31.8 (CH2), 119.9, 125.9, 126.0, 128.5, 128.9, 133.0,
134.6, 142.1, 145.4, 148.2, 155.1, 161.1, 163.8 and 169.0
ppm (Ar-C and CO); MS (EI): m/z (%) 373 (M++1, 6.18),
372 (M+, 24.79); HRMS (EI): m/z calcd. for C17H13ClN4O2S
(M+) 372.0442, found 372.0442.
N-(4-Chlorophenyl)-2-[(4-oxo-3,4-dihydroquinazolin-2-yl)-
thio]acetamide (16)
A solution of ethyl-2-[(4-oxo-3,4,-dihydroquinazolin-
2-yl)thio]acetate (10) (1.32 g, 5 mmol), 4-chloro-
aniline (0.70 g, 5 mmol) in acetic acid (25 mL) was
stirred at reflux for 5 h. The separated solid product
obtained on standing at room temperature was collected
by filtration, washed by EtOH and recrystallized from
dioxane as white crystals, yield: 84%, m.p. 276–278°C; IR
(KBr): v /cm−1 3406, 3185 (2NH), 1687 (br 2CO); 1H-
NMR (DMSO-d6): δ = 3.38 (s, 2H, CH2), 7.25 (t, J = 7.6
Hz, 1H, Ar-H), 7.39-7.42 (m, 3H, Ar-H), 7.67 (t, J = 7.6
Hz, 1H, Ar-H), 7.78 (d, J = 8.0 Hz, 2H, Ar-H), 7.98 (d, J
= 7.6 Hz, 1H, Ar-H), 8.83 (s, 1H, NH) and 10.87 ppm
(s, 1H, NH); 13C-NMR (DMSO-d6): δ = 24.0 (CH2),
118.4, 120.8, 123.2, 125.3, 125.9, 128.6, 134.4, 138.0, 147.2,
149.7, 161.6, 168.4 and 172.0 ppm (Ar-C and CO); MS
(EI): m/z (%) 346 (M++1, 3.74), 345 (M+, 11.25); HRMS
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Carbon disulphide (20 mmol) was added drop wise to an
ice cold solution of potassium hydroxide (10 mmol) in
absolute alcohol (30 ml) containing acetohydrazide 14
(1.25 g, 5 mmol). The reaction mixture was stirred con-
tinuously for 24 h at room temperature. The precipitated
potassium thiocarbamate 17 was filtered off, washed
with chilled diethyl ether then dried and directly used
for the next step without further purification. The above
potassium thiocarbamate was mixed with water (8 mL)
and hydrazine hydrate (15 mmol) and refluxed for 4 h.
The reaction mixture turned green with evolution of
hydrogen sulphide and finally it became homogeneous.
The reaction mixture was cooled to room temperature
and poured onto ice cold water. On acidification with
acetic acid, the required triazole 18 was precipitated
then filtered off and washed with cold water and dried.
It was purified by recrystallization from EtOH/DMF
(1:2) mixture to get white, crystalline solid. yield: 66%,
m.p. 204–205°C; IR (KBr): v /cm−1 3327, 3301, 3263,
3202 (2NH and NH2), 1665 (CO);
1H-NMR (DMSO-d6):
δ = 4.40 (s, 2H, CH2), 5.43(s, 2H, NH2 D2O exchange-
able ), 7.14 (t, J = 8.0 Hz, 1H, Ar-H), 7.32 (d, J = 8.0 Hz,
1H, Ar-H), 7.60 (t, J = 8.0 Hz, 1H, Ar-H), 7.93 (d, J = 8.0
Hz, 1H, Ar-H), 12.85 (s, 1H, NH) and 13.87 ppm (s, 1H,
NH); 13C-NMR (DMSO-d6): δ = 32.3 (CH2), 116.5,
121.1, 121.6, 124.4, 126.1, 134.0, 148.6, 152.6, 161.0 and
166.5 ppm (Ar-C and CO); MS (EI): m/z (%) 307 (M++1,
21.62), 306 (M+, 100); HRMS (EI): m/z calcd. for
C11H10N6OS2 (M
+) 306.0352, found 306.0354.N-(2-Hydroxyethyl)-2-[(4-oxo-3,4-dihydroquinazolin-2-yl)-
thio]acetamide (19)
Mixture of ethyl-2-[(4-oxo-3,4,-dihydroquinazolin-2-yl)
thio]acetate (10) (2.64 g, 10 mmol), ethanolamine (1.22
g, 20 mmol) in ethanol (25 mL) was stirred at reflux for
4 h. The separated solid product obtained on standing at
room temperature was collected by filtration, washed by
water and recrystallized from EtOH as colorless crystals,
yield: 71%, m.p. 228–229°C; IR (KBr): v /cm−1 3385,
3267, 3202 (2NH and OH), 1689, 1629 (2CO); 1H-NMR
(DMSO-d6): δ = 3.35 (s, 2H, CH2), 3.40 (q, 2H, J = 5.6
Hz, CH2OH), 3.56 (t, 2H, J = 5.6 Hz, NHCH2), 4.94
(br, 1H,OH, D2O exchangeable), 6.37 (s, 1H,NH), ), 7.10
(t, J = 8.0 Hz, 1H, Ar-H), 7.24 (d, J = 8.0 Hz, 1H, Ar-H),
7.56 (t, J = 8.0 Hz, 1H, Ar-H), 7.88 (d, J = 8.0 Hz, 1H,
Ar-H) and 9.86 ppm (s, 1H, NH); MS (EI): m/z (%) 280
(M++1, 3.88), 279 (M+, 15.09); HRMS (EI): m/z calcd.
for C12H13N3O3S (M
+) 279.0672, found 279.0671.Conclusions
In conclusion a simple and efficient one-pot synthe-
sis of a novel class of 2-arylidene-2H-thiazolo[3,2-a]-
quinazoline-1,5-diones 9a-i was established through
DABCO catalyzed Michael type addition reaction. In
addition many fused quinazoline and quinazoline deriva-
tives were synthesized which appeared as valuable pre-
cursors in synthetic and medicinal chemistry. Moreover
the X-ray single crystal technique was successfully
employed in this study for structure elucidation, Z/E
potential isomerism configuration determination and to
determine the regioselectivity of the reactions.
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